Sun Pharma appoints Jeremy Allen as Vice President, Corporate Affairs for North America
Written By : Ruchika Sharma
Published On 2025-10-24 06:00 GMT | Update On 2025-10-24 06:01 GMT
Advertisement
Princeton: Sun Pharmaceutical Industries Limited has announced the appointment of Jeremy Allen as Vice President, Corporate Affairs for North America.
In this newly created position, Jeremy will lead Sun Pharma's Government Affairs, Public Policy, Advocacy and Communications across the U.S. and Canada.
"We are thrilled to welcome Jeremy to Sun Pharma," said Richard Ascroft, Sun Pharma CEO, North America. "With his expertise and strategic vision, Jeremy will serve an integral role in the continued growth of our business. As the VP of Corporate Affairs, Jeremy and his team will strengthen our engagement with stakeholders, shape policy environments, and ensure our voice reflects the values and priorities of the people who rely on our Innovative Medicines, Generics and Consumer Healthcare products."
In this role, Jeremy will lead Sun Pharma's external engagement, policy initiatives, patient advocacy, government relations, and corporate communications across the United States and Canada. A seasoned healthcare leader with more than 25 years of industry experience, Jeremy has an extensive background in developing and leading campaign-style policy initiatives. Jeremy joins Sun Pharma from Spark Therapeutics, where he led the U.S. government affairs and pricing & reimbursement functions.
"I'm honored to join Sun Pharma at such a pivotal time in its growth journey. As the company continues to expand its footprint across the U.S. and Canada, I look forward to helping shape and share the story of Sun Pharma's commitment to improving patient lives through accessible, high-quality medicines," said Jeremy Allen, VP Corporate Affairs, Sun Pharma North America. "As Sun Pharma launches new Innovative Medicines that address unmet patient needs and Generics that play a vital role in lowering costs for the healthcare system, this role will be pivotal in continuing the Company's efforts to build trust, deepen existing relationships and ensure we're meeting the needs of the patient communities we serve."
Prior to his time with Spark, Jeremy led the federal lobbying team at AHIP (formerly known as America's Health Insurance Plans) and held government affairs roles at Vertex Pharmaceuticals and Johnson & Johnson. Jeremy began his career in government, working both on Capitol Hill and at the Centers for Disease Control and Prevention.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.